167 related articles for article (PubMed ID: 1418732)
1. Monoclonal antibodies in the study and therapy of hematopoietic cancers.
Matthews DC; Smith FO; Bernstein ID
Curr Opin Immunol; 1992 Oct; 4(5):641-6. PubMed ID: 1418732
[TBL] [Abstract][Full Text] [Related]
2. Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.
Scheinberg DA
Curr Opin Immunol; 1991 Oct; 3(5):679-84. PubMed ID: 1661602
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody-based therapies of leukemia and lymphoma.
Grossbard ML; Press OW; Appelbaum FR; Bernstein ID; Nadler LM
Blood; 1992 Aug; 80(4):863-78. PubMed ID: 1498329
[No Abstract] [Full Text] [Related]
4. Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates.
Sievers EL
Cancer Chemother Pharmacol; 2000; 46 Suppl():S18-22. PubMed ID: 10950142
[TBL] [Abstract][Full Text] [Related]
5. Antibody-targeted therapy for myeloid leukemia.
Appelbaum FR
Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
[TBL] [Abstract][Full Text] [Related]
6. [Use of antibodies or their fragments for the treatment of tumors].
Douillard JY; Chatal JF
Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422
[TBL] [Abstract][Full Text] [Related]
7. Advances in monoclonal antibody therapy of cancer.
LoBuglio AF; Saleh MN
Am J Med Sci; 1992 Sep; 304(3):214-24. PubMed ID: 1476160
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibodies for lymphomas and leukemias in 2005].
Peffault de Latour R; Robin M; Bay JO
Bull Cancer; 2006 Jan; 93(1):107-18. PubMed ID: 16455513
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody therapy of leukemia and lymphoma.
Jurcic JG; Caron PC; Scheinberg DA
Adv Pharmacol; 1995; 33():287-314. PubMed ID: 7495673
[No Abstract] [Full Text] [Related]
10. Immunotoxin therapy of lymphoma.
Grossbard ML; Nadler LM
Cancer Treat Res; 1993; 68():111-31. PubMed ID: 8105846
[No Abstract] [Full Text] [Related]
11. Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Buchmann I; Bunjes D; Kotzerke J; Martin H; Glatting G; Seitz U; Rattat D; Buck A; Döhner H; Reske SN
Cancer Biother Radiopharm; 2002 Apr; 17(2):151-63. PubMed ID: 12030109
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxins in the therapy of leukemias and lymphomas.
Hertler AA; Frankel AE
Cancer Invest; 1991; 9(2):211-9. PubMed ID: 1863876
[No Abstract] [Full Text] [Related]
13. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
Fishwild DM; Aberle S; Bernhard SL; Kung AH
Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534
[TBL] [Abstract][Full Text] [Related]
15. Cell surface receptor-targeted therapy of acute myeloid leukemia: a review.
Frankel AE; Sievers EL; Scheinberg DA
Cancer Biother Radiopharm; 2000 Oct; 15(5):459-76. PubMed ID: 11155818
[TBL] [Abstract][Full Text] [Related]
16. CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy.
Scheuermann RH; Racila E
Leuk Lymphoma; 1995 Aug; 18(5-6):385-97. PubMed ID: 8528044
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
Strom TB; Kelley VR; Murphy JR; Nichols J; Woodworth TG
Adv Nephrol Necker Hosp; 1994; 23():347-56. PubMed ID: 8154364
[No Abstract] [Full Text] [Related]
18. Immunotoxins for treatment of leukemia and lymphoma.
Uckun FM; Reaman GH
Leuk Lymphoma; 1995 Jul; 18(3-4):195-201. PubMed ID: 8535182
[TBL] [Abstract][Full Text] [Related]
19. Antibodies in the treatment of lymphoma.
Harvey ML; Illidge T; Johnson P
Clin Oncol (R Coll Radiol); 2001; 13(4):251-61. PubMed ID: 11554621
[No Abstract] [Full Text] [Related]
20. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
